Tratamiento con dexametasona en caso de infección por COVID-19: informe rápido de evaluación de tecnología sanitaria

Tortosa, Fernando; Balaciano, Giselle; Carrasco, Gabriela; Cháves, Clelia; Garda, Darlo; Montero, Guadalupe; Rucci, Pablo; Sanguine, Verónica.
Rev. argent. salud publica ; 12(supl.1): 15-15, oct. 2020. graf
Artículo en Español | LILACS-Express | ID: biblio-1155726

Documentos relacionados

  1. Tratamiento con Dexametasona en caso de infección por COVID-19 Informe rápido de evaluación de tecnología sanitaria
  2. Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia.
  3. Delayed dexamethasone treatment at initiation of oxygen supplementation for coronavirus disease 2019 is associated with the exacerbation of clinical condition.
  4. A Comparison of the Efficacy of Adjuvant Parenteral Methylprednisolone and Dexamethasone in Reducing Covid-19 Disease Severity and Mortality among the Moderate to Critical Patients -A Retrospective Study.
  5. Real-world effectiveness of steroids in severe COVID-19: a retrospective cohort study.
  6. Effect of high <i>versus</i> low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial.
  7. Prolonged higher dose methylprednisolone <i>versus</i> conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS).
  8. Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: a randomized clinical trial.
  9. Convalescent plasma for people with COVID-19: a living systematic review.
  10. The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.